LeaderPortfolio
Klatten
Susanne Klatten
Rank #77
GERMANYautomotiveBMW, pharmaceuticals

Susanne Klatten

Net Worth
$29.691B
0% (24h)
Susanne Klatten (born April 28, 1962) is a German billionaire heiress and businesswoman. Her estimated net worth as of February 2, 2026, is $28.1 billion, making her one of the wealthiest individuals globally. Her wealth stems from her significant holdings in BMW, pharmaceuticals, and other investments. Klatten's career includes transforming Altana AG into a world-class pharmaceutical and specialty chemical corporation and serving on the supervisory board of BMW. She is known for her strategic vision and commitment to excellence within her business ventures. Klatten also focuses on philanthropic endeavors through her SKala Initiative, supporting education, science, and cultural initiatives.

The Full Dossier

Early Life

Susanne Hanna Ursula Quandt was born on April 28, 1962, in Bad Homburg, Germany. She is the daughter of Herbert Quandt, a prominent industrialist, and Johanna Quandt. Growing up in a wealthy family, she was exposed to business from an early age, with her father's legacy and the family's ties to the automotive industry shaping her future. After graduating with a degree in business finance, she began her career.

Rise to Success

Klatten started her career with an apprenticeship at the advertising agency Young & Rubicam in Frankfurt from 1981 to 1983. She furthered her education with courses in marketing and management at the University of Buckingham and an MBA from IMD Business School in Lausanne. She also gained practical experience at institutions like Dresdner Bank, McKinsey, and Bankhaus Reuschel & Co.. Her father's death led her to inherit his 50.1% stake in Altana AG, a pharmaceutical and chemical manufacturer. Klatten transformed Altana into a leading global corporation. She also holds a 19% stake in BMW and serves on the supervisory board.

Key Business Strategies

Klatten's business strategies include strategic investments, particularly in BMW, Altana, and other sectors like renewable energy and biotechnology through her investment firm, SKion GmbH. Her focus is on innovation, sustainability, and operational excellence. She emphasizes a hands-on approach, contributing to the strategic growth of the companies she's involved in.

Philanthropy

Susanne Klatten is actively involved in philanthropy, supporting various causes, particularly in education, science, and healthcare. She established the SKala Initiative, which focuses on supporting social and charitable projects throughout Germany, addressing education inequality, youth development, and medical research. Her philanthropic efforts are guided by a principle of creating lasting impact.

Career Timeline

2006

Altana's Pharmaceutical Division Sale

Altana AG sold its pharmaceutical activities for €4.5 billion.

1997

Joined BMW Supervisory Board

Joined the Supervisory Board of BMW AG with her brother.

1990

Joined Altana Supervisory Board

Joined Altana's supervisory board, which her father founded

1981-1983

Advertising Agency

Worked at Young & Rubicam in Frankfurt

Philanthropic Impact

Social and Charitable ProjectsUndisclosed

SKala Initiative

Supports social and charitable projects, focusing on education, youth development, and medical research.

Wealth Trajectory